TB202-63

N/A

Report date: 2025/01/26 16:02:00

Base Information

Drug NameTB202-63
Drug Alias Namesingle domain VHH nanobody (Twist Bioscience)single domain VHH nanobody (Twist Bioscience)TB202-63
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTwist Bioscience Corp
China Registration ClassN/A

Develop Information

Active CompaniesTwist Bioscience Corp
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A